Thailand has ordered an additional 30 million doses of the Pfizer (NYSE:PFE)/ BioNTech's (Nasdaq:BNTX) COVID-19 vaccine, Reuters news agency reported on Tuesday.
Government spokesman Thanakorn Wangboonkongchana said that delivery under this order is expected to begin in the first quarter of next year.
This latest order is on top of 30 million Pfizer-BioNTech shots due to arrive this year and 60 million doses of the AstraZeneca (LON:AZN) COVID-19 due for 2022.
Clover Bio announces SCB-1019 vaccine candidate Phase I trial data in initial young adult cohort
Sanofi launches Verorab for rabies prophylaxis in UK
BioVaxys expands patent portfolio for DPX delivery platform and advances DPX SurMAGE
VGXI names new chief accounting officer
Moderna reports positive interim results from next-generation COVID-19 vaccine trial
Valneva launches Phase 1 trial for next-generation Zika vaccine
Circio Holding ASA confirms licensing deal with IOVaxis Therapeutics in China and Singapore
Everest Medicines names new chief medical officer and chief product officer
Pfizer's PREVENAR 20 gains European Commission approval for paediatric pneumococcal vaccine
Virbac expands presence in Japan with Sasaeah acquisition
Pfizer reveals strong efficacy data for ABRYSVO in older adults against RSV